http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2774446-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98f5bc87320d5e6f71d64b6894c4df87
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
filingDate 2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_173fd2b4e04c73eac1d7d9e81986cd53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6a3fa7f2ea1565995e96c2cbe802937
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c80ac903f5effe6490a5bbf061e906fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4dda71741554bcbddc12e7c80d00e43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d11fc87cff25c35a181f62c29c4ce86c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d2b5192227bb8c19ff250f98b271fbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cd0df9ec5d63c66f7f790f69677d207
publicationDate 2011-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2774446-A1
titleOfInvention Hiv-1 antibodies
abstract The present invention relates, in general, to HIV-1 specific antibodies and, in particular, to broadly neutralizing HIV-1 specific antibodies that target the gp41 membrane-proximal external region (MPER). The present invention also relates to a cell culture system, more specifically, to a method of rendering chronic lymphocytic leukemia B-cells immortal and to a method of isolating anti-viral antibodies from clones of such cells.
priorityDate 2009-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282602
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID338457
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551199
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF7EDI8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415781439
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28388
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9NR96
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2909
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCM0RAA8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81897
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A2R8QA47
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86398
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID493839
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49357
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456490753
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403128
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5I2M8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5I2M7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6Y1S0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5I2M5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5I2M4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64006
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C781
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCBAG55070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5I2M3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2EEY0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA5H631
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54106

Total number of triples: 64.